The New York Times reports today that there is an Adderall shortage nationwide, affecting perhaps hundreds of thousands or even millions of people.  As someone who takes antidepressants for my unipolar depression, I can empathize greatly with all of you out there, feeling almost a sense of panic if I weren’t able to get my...Read More

ADHD continues to occur at epidemic levels in our society.  Thirty-five years ago, only a handful of children and teens were considered to have what at the time was called ‘’hyperkinesis’’ or ‘’minimal brain dysfunction.’’ Now, the diagnosis takes in almost 10% of all children and teens.  Most of these kids (62%) are taking ADHD...Read More

I read an online article today from Benzinga, a financial media company that empowers its readers with daily actionable market analysis and commentary.  It reported on a new ADHD drug that the FDA had just approved, called Cotempla XR-OTD, a methylphenidate extended release orally-disintegrating tablet for treating ADHD in kids aged 6-17.  According to BMO...Read More

A new study of Scottish children published in the JAMA Pediatrics this week, suggests that the 1.0% of subjects (N= 7413) that were being medicated for attention deficit hyperactivity disorder had poorer outcomes on a wide range of measures compared with others in the study (N=766,244). The outcomes included: poor academic attainment, unauthorized absence from...Read More

I’ve been concerned about the lack of input that children and adolescents diagnosed with ADHD have relating to their diagnosis and treatment.  Now a new study in the May 2017 issue of the Community Mental Health Journal reports that children with a diagnosis of ADHD want to talk with their doctors about their diagnosis and the...Read More